 MicroRNAs, mRNAs, are small, non-coding RNAs that regulate the expression of genes involved in many biological processes, including cell growth and differentiation. They have been found to be dysregulated in various types of cancer, suggesting that they may play important roles in tumor development and progression. Several mRNAs have been identified as potential targets for cancer therapy, and some have already been tested in clinical trials. These studies suggest that mRNAs could provide a novel approach for treating cancer by targeting specific pathways or genes associated with tumor genesis. However, there are still many challenges to overcome before mRNAs can be used in the clinic, such as identifying the most effective mRNA-based therapeutics and developing delivery systems that can effectively deliver them to tumors. This article was authored by Matri Wyshaw, Alessandra Farajoli, Anil K. Sud and others.